| scholarly article | Q13442814 |
| P50 | author | Tarita Biver | Q46204145 |
| Gustavo Espino | Q56987603 | ||
| José M Leal | Q56987622 | ||
| Félix A. Jalón | Q60632546 | ||
| Natalia Busto | Q39051704 | ||
| Jorge F. Gaspar | Q41357628 | ||
| P2093 | author name string | Ana M Rodríguez | |
| Begoña García | |||
| Blanca R Manzano | |||
| Cristina Aliende | |||
| Jesús Valladolid | |||
| Celia Martins | |||
| P2860 | cites work | Emerging protein targets for anticancer metallodrugs: inhibition of thioredoxin reductase and cathepsin B by antitumor ruthenium(II)-arene compounds | Q46403140 |
| Effect of poly(ADP-ribosyl)ation inhibitors on the genotoxic effects of the boron neutron capture reaction | Q46468298 | ||
| DNA binding and topoisomerase II inhibitory activity of water-soluble ruthenium(II) and rhodium(III) complexes | Q46901067 | ||
| Mechanism of intercalation into the DNA double helix by ethidium. | Q52397229 | ||
| NMR Chemical Shifts of Trace Impurities: Common Laboratory Solvents, Organics, and Gases in Deuterated Solvents Relevant to the Organometallic Chemist | Q55952106 | ||
| Arene ruthenium(II) complexes formed by dehydrogenation of cyclohexadienes with ruthenium(III) trichloride | Q56528901 | ||
| Determining the binding mode of DNA sequence specific compounds | Q56950204 | ||
| Kinetics of aquation and anation of ruthenium(II) arene anticancer complexes, acidity and X-ray structures of aqua adducts. | Q30886115 | ||
| A multilateral mechanistic study into asymmetric transfer hydrogenation in water | Q31161692 | ||
| Analysis of thermal melting curves. | Q33199690 | ||
| Ruthenation of duplex and single-stranded d(CGGCCG) by organometallic anticancer complexes | Q33248329 | ||
| Development of organometallic ruthenium-arene anticancer drugs that resist hydrolysis | Q33260994 | ||
| Unusual DNA binding modes for metal anticancer complexes | Q34071185 | ||
| The in vitro micronucleus technique | Q34102908 | ||
| Highly selective binding of organometallic ruthenium ethylenediamine complexes to nucleic acids: novel recognition mechanisms. | Q34168916 | ||
| Criteria for the mode of binding of DNA binding agents. | Q36684372 | ||
| Ruthenium complexes can target determinants of tumour malignancy | Q36764499 | ||
| Catalytic organometallic anticancer complexes | Q36823229 | ||
| In vitro and in vivo activity and cross resistance profiles of novel ruthenium (II) organometallic arene complexes in human ovarian cancer | Q37352731 | ||
| Current applications and future potential for bioinorganic chemistry in the development of anticancer drugs. | Q37603642 | ||
| Thermodynamic extent of counterion release upon binding oligolysines to single-stranded nucleic acids | Q37742304 | ||
| Targeted and multifunctional arene ruthenium chemotherapeutics | Q37920741 | ||
| An improved method for the 'in vitro' micronucleus test using human lymphocytes | Q37924421 | ||
| Arene ruthenium complexes as anticancer agents | Q39706669 | ||
| Biological assays and noncovalent interactions of pyridine-2-carbaldehyde thiosemicarbazonecopper(II) drugs with [poly(dA-dT)](2), [poly(dG-dC)] (2), and calf thymus DNA. | Q39750186 | ||
| Thermodynamic analysis of ion effects on the binding and conformational equilibria of proteins and nucleic acids: the roles of ion association or release, screening, and ion effects on water activity | Q39750512 | ||
| Tetranuclear coordination assemblies based on half-sandwich ruthenium(II) complexes: noncovalent binding to DNA and cytotoxicity. | Q39827508 | ||
| Inhibition of cancer cell growth by ruthenium(II) cyclopentadienyl derivative complexes with heteroaromatic ligands. | Q39897986 | ||
| Solid-phase synthesis and antitumor evaluation of 2,4-diamino-6-aryl-1,3,5-triazines | Q39898317 | ||
| Synthesis, structure and anticancer activity of novel alkenyl-1,3,5-triazine derivatives | Q40304375 | ||
| Synthesis, structure and anticancer activity of novel 2,4-diamino-1,3,5-triazine derivatives. | Q40336377 | ||
| V79-hCYP2E1-hSULT1A1, a cell line for the sensitive detection of genotoxic effects induced by carbohydrate pyrolysis products and other food-borne chemicals. | Q40466470 | ||
| Synthesis, characterization, interaction with DNA and cytotoxicity of the new potential antitumour drug cis-K[Ru(eddp)Cl(2)]. | Q40631136 | ||
| Inhibition of cancer cell growth by ruthenium(II) arene complexes | Q40774119 | ||
| Change of the binding mode of the DNA/proflavine system induced by ethanol. | Q43044324 | ||
| Inhibitory effects of anti-tumor platinum compounds on DNA, RNA and protein syntheses in mammalian cells in virtro | Q44552882 | ||
| Equilibria and kinetics of the intercalation of Pt-proflavine and proflavine into calf thymus DNA. | Q44588223 | ||
| DNA Interactions of Monofunctional Organometallic Ruthenium(II) Antitumor Complexes in Cell-free Media | Q44600759 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 788-801 | |
| P577 | publication date | 2012-02-03 | |
| P1433 | published in | Chemistry - An Asian Journal | Q2962570 |
| P1476 | title | Preparation of organometallic ruthenium-arene-diaminotriazine complexes as binding agents to DNA. | |
| P478 | volume | 7 |
| Q52872859 | Alteration of steric hindrance modulates glutathione resistance and cytotoxicity of three structurally related Ru(II)-p-cymene complexes. |
| Q39044622 | Phenanthroline ligands are biologically more active than their corresponding ruthenium(II) arene complexes. |
| Q92942090 | Programmed Molecular Construction: Driving the Self-Assembly by Coordination and Hydrogen Bonds Using 6-(Pyridin-2-yl)-1,3,5-triazine-2,4-diamine with M(NO3)2 Salts |
| Q39121561 | Ruthenium-Arene-β-Carboline Complexes as Potent Inhibitors of Cyclin-Dependent Kinase 1: Synthesis, Characterization and Anticancer Mechanism Studies. |
| Q90167598 | Synthesis and biological activity of novel zinc-itraconazole complexes in protozoan parasites and Sporothrix spp |
Search more.